Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A Knauf, Xiao-Hui Liao, Brian L West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M Larson, Samuel Refetoff, Ronald Ghossein, James A Fagin. J Clin Invest 2011
Times Cited: 240
Times Cited: 240
Laurie L Carr, David A Mankoff, Bernardo H Goulart, Keith D Eaton, Peter T Capell, Elizabeth M Kell, Julie E Bauman, Renato G Martins. Clin Cancer Res 2010
Times Cited: 288
Times Cited: 288
List of shared articles
Times cited
Emerging drugs for the treatment of radioactive iodine refractory papillary thyroid cancer.
Sophie Leboulleux, Livia Lamartina, Julien Hadoux, Eric Baudin, Martin Schlumberger. Expert Opin Investig Drugs 2022
Sophie Leboulleux, Livia Lamartina, Julien Hadoux, Eric Baudin, Martin Schlumberger. Expert Opin Investig Drugs 2022
Multikinase inhibitors in thyroid cancer: timing of targeted therapy.
Matti L Gild, Venessa H M Tsang, Roderick J Clifton-Bligh, Bruce G Robinson. Nat Rev Endocrinol 2021
Matti L Gild, Venessa H M Tsang, Roderick J Clifton-Bligh, Bruce G Robinson. Nat Rev Endocrinol 2021
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm.
Vincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, Antonio Daponte, Fabio Sandomenico, Paolo Vallone, Luciana Costigliola, Gerardo Botti, Franco Ionna, Luciano Pezzullo. Crit Rev Oncol Hematol 2021
Vincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, Antonio Daponte, Fabio Sandomenico, Paolo Vallone, Luciana Costigliola, Gerardo Botti, Franco Ionna, Luciano Pezzullo. Crit Rev Oncol Hematol 2021
Early Predictive Response to Multi-Tyrosine Kinase Inhibitors in Advanced Refractory Radioactive-Iodine Differentiated Thyroid Cancer: A New Challenge for [18F]FDG PET/CT.
Cristina Ferrari, Giulia Santo, Rossella Ruta, Valentina Lavelli, Dino Rubini, Paolo Mammucci, Angela Sardaro, Giuseppe Rubini. Diagnostics (Basel) 2021
Cristina Ferrari, Giulia Santo, Rossella Ruta, Valentina Lavelli, Dino Rubini, Paolo Mammucci, Angela Sardaro, Giuseppe Rubini. Diagnostics (Basel) 2021
Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics.
Yuchen Jin, Min Liu, Ri Sa, Hao Fu, Lin Cheng, Libo Chen. Cancer Lett 2020
Yuchen Jin, Min Liu, Ri Sa, Hao Fu, Lin Cheng, Libo Chen. Cancer Lett 2020
Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience.
Matea Pešorda, Sanja Kusačić Kuna, Dražen Huić, Davorin Herceg, Marija Despot, Tatjana Samardžić, Milena Gnjidić, Borislav Belev. Acta Clin Croat 2020
Matea Pešorda, Sanja Kusačić Kuna, Dražen Huić, Davorin Herceg, Marija Despot, Tatjana Samardžić, Milena Gnjidić, Borislav Belev. Acta Clin Croat 2020
Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer.
Steven P Weitzman, Steven I Sherman. Endocrinol Metab Clin North Am 2019
Steven P Weitzman, Steven I Sherman. Endocrinol Metab Clin North Am 2019
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
Clinical guidance for radioiodine refractory differentiated thyroid cancer.
Matti L Gild, Duncan J Topliss, Diana Learoyd, Francis Parnis, Jeanne Tie, Brett Hughes, John P Walsh, Donald S A McLeod, Roderick J Clifton-Bligh, Bruce G Robinson. Clin Endocrinol (Oxf) 2018
Matti L Gild, Duncan J Topliss, Diana Learoyd, Francis Parnis, Jeanne Tie, Brett Hughes, John P Walsh, Donald S A McLeod, Roderick J Clifton-Bligh, Bruce G Robinson. Clin Endocrinol (Oxf) 2018